Phase 1 Ulcerative colitis trials recruiting now
All Ulcerative colitis trials, every phase
19
Phase 1 recruiting
Other phases for Ulcerative colitis
Phase 1 Ulcerative colitis trials
- A Phase I Study to Evaluate the Safety/Tolerability of BDHK-2009 Tablets in Healthy Adult
- A Phase Ib/IIa Study of INT-210 Capsules in Participants With Active Ulcerative Colitis
- A Safety and Pharmacokinetics Study of TL-003 in Healthy Adults and Open-label Assessments in Participants With Ulcerative Colitis
- A Study of AC-101 Tablets in Participants With Moderate to Severe Active Ulcerative Colitis
- A Study of MB-001 in Moderately to Severely Active Ulcerative Colitis
- A Study of Single and Multiple Ascending Doses of H021 in Healthy Participants
- A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ONO-6414 Administered Orally in Healthy Adult Participants and Patients With Active Ulcerative Colitis
- An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis
- An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab
- Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease
- FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach
- Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population
- Fluorescence Imaging of Risankizumab-800CW in Inflammatory Bowel Disease
- R-3750 in Patients With Mild to Moderate Ulcerative Colitis
- Safety, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Ascending Doses BCD-261 in Healthy Subjects
- Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Study to Evaluate the Fecal Microbiota Transplantation (FMT) in the Treatment of Ulcerative Colitis
- Superdonor FMT in Patients With Ulcerative Colitis
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Common questions
What does Phase 1 mean?
Is this list complete?
No. For the full record, search ClinicalTrials.gov.